Please use this identifier to cite or link to this item:
|Title:||Survival in Norwegian BRCA1 mutation carriers with breast cancer|
|Authors:||Hagen, Anne Irene;Tretli, Steinar;Mæhle, Lovise;Apold, Jaran;Vedå, Nina;Møller, Pål|
|Description:||<p>Several studies of survival in women with BRCA1 mutations have shown either reduced survival or no difference compared to controls. Programmes for early detection and treatment of inherited breast cancer, have failed to demonstrate a significant improvement in survival in BRCA1 mutation carriers.</p> <p>One hundred and sixty-seven women with disease-associated germline BRCA1 mutations and breast cancer from 1980 to 2001 were identified. Tumour characteristics, treatment given and survival were recorded. A control group comprising three hundred and four women matched for age, time of diagnosis and stage were used to compare survival.</p> <p>BRCA1 mutation carriers were found to have a poorer prognosis, which could be explained by neither the mode of surgical treatment nor the use of adjuvant chemotherapy. BRCA1 mutation carriers with node negative breast cancer had worse overall survival than controls.</p> <p>Our findings confirm the serious prognosis of BRCA1-associated breast cancer even when diagnosed at an early stage, and that type of treatment does not influence prognosis.</p>|
|Standard no:||Hereditary Cancer in Clinical Practice 7(1):7|
|Appears in Collections:||Faculty of Medicine and Dentistry|
Files in This Item:
Click on the URI links for accessing contents.
Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.